A note on the power of Fisher's least significant difference procedure

Pharmaceutical Statistics

Volumn 5, Issue 4, 2006, Pages 253-263

  Meier, Ulrich ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Fisher's least significant difference procedure; Multiple comparisons

Indexed keywords

ALZHEIMER DISEASE; ANALYTICAL ERROR; ARTICLE; CLINICAL RESEARCH; COMPARATIVE STUDY; DATA ANALYSIS; EFFECT SIZE; FISHER LEAST SIGNIFICANT DIFFERENCE; METHODOLOGY; NULL HYPOTHESIS; OUTCOME ASSESSMENT; PARAMETRIC TEST; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANALYSIS OF VARIANCE; BIOMETRY; CLINICAL TRIALS; CLINICAL TRIALS, PHASE III; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; HUMANS; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PLACEBOS; RESEARCH; RESEARCH DESIGN; SAMPLE SIZE; TECHNOLOGY, PHARMACEUTICAL;

EID: 33845890346     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.210     Document Type: Article

References (13)

1. Marcus R, Peritz E, Gabriel KR. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 1976; 63(3):655-660.
2. Holm S. A simple sequentially rejecting multiple test procedure. Scandinavian Journal of Statistics 1979; 6:65-70.
3. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 75(4):800-802.
4. Samuel-Cahn E. Is the Simes improved Bonferroni procedure conservative? Biometrika 1996; 83(4):928-933 (Erratum in Biometrika 2004; 91(1):249).
5. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. American Journal of Psychiatry 1984; 141(11):1356-1364.
6. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on medicinal products in the treatment of Alzheimer's disease. The European Agency for the Evaluation of Medicinal Products: London, September 1997.
7. Leber P. Guidelines for the clinical evaluation of antidementia drugs. Draft FDA guideline (with-drawn), 8 November 1990.
8. Reisberg B, Schneider L, Doody R, Anand R, Feldman H, Haraguchi H, Kumar R, Lucca U, Mangone CA, Mohr E, Morris JC, Rogers S, Sawada T. Clinical global measures of dementia: Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Disease Associated Disorders 1997; 11(Suppl. 3):8-18.
9. Arnold SF. The theory of linear models and multivariate analysis. Wiley: New York, 1981.
10. Johnson NL, Kotz S, Balakrishnan N. Continuous univariate distributions (2nd edn), Vol. 2. Wiley: New York, 1995.
11. Scheffé H. The analysis of variance. Wiley: New York, 1959.
12. Searle SR. Matrix algebra useful for statistics. Wiley: New York, 1982.
13. Rohatgi VK. An introduction to probability theory and mathematical statistics. Wiley: New York, 1976.